Inhibrx Biosciences, Inc. INBX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s free cash flow margin?
- Inhibrx Biosciences, Inc. (INBX) reported free cash flow margin of -9,986.5% in Q4 2025.
- How has Inhibrx Biosciences, Inc.'s free cash flow margin changed year-over-year?
- Inhibrx Biosciences, Inc.'s free cash flow margin increased by 89.9% year-over-year, from -98,503% to -9,986.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.